Aspirin plus one blood thinner versus aspirin plus clopidogrel
Part of Heart & circulation clinical trials.
This trial compares two common “blood thinner” combinations to prevent problems after a PCI procedure for complex blocked heart arteries. It may help your care team find which combination works better for people with higher-risk artery patterns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old (no upper age limit is stated, but other age limits apply).
- You (or your legal representative) can understand and agree in writing to the study plan and safety information.
- You are having an elective PCI for a complex blockage, such as true bifurcation, chronic total blockage, left main disease, long lesions (expected stent length 38 mm or more), multi-vessel treatment, or needing 3+ stents.
- Your target lesion is one of the listed types, including in-stent restenosis, severely calcified blockage, or certain opening/ostial blockages.
- You must not have serious current bleeding, recent brain bleeding, or a history of stroke or transient ischemic attack (TIA).
- You cannot be on warfarin or certain other anticoagulants (dabigatran, rivaroxaban, edoxaban, apixaban), and you should not be taking prasugrel or ticagrelor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.
This study compares two ways of choosing blood thinners after a heart stent procedure. It aims to see if using an imaging-guided strategy leads to better outcomes than usual care.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This Phase 3 trial compares two strategies to prevent blood clots after heart bypass surgery: aspirin alone versus aspirin plus ticagrelor. It aims to see which approach works better and is safer for people whose bypass does not fully restore blood flow.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.